Soluble Transferrin Receptors (STFR), Catalog Number TF10159 (Research Use Only). IVD
FDA Device Recall #Z-1422-2022 — Class III — June 9, 2022
Recall Summary
| Recall Number | Z-1422-2022 |
| Classification | Class III — Low risk |
| Date Initiated | June 9, 2022 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Randox Laboratories Ltd. |
| Location | Crumlin (North), N/A |
| Product Type | Devices |
| Quantity | 12 kits (US) |
Product Description
Soluble Transferrin Receptors (STFR), Catalog Number TF10159 (Research Use Only). IVD
Reason for Recall
A customer reported a problem with the reagent and calibrator. Randox Laboratories carried out an investigation and confirmed the issue. The complaint is pertaining to atypical calibration curves that can results in non-numerical results. This affects Siemens Atellica CH analysers only. Customer have reported an atypical calibration curve that results in the values around the low QC range to produce a non-numerical result. It appears to be related to the bottle values of the calibrator producing a curve shape that is too linear for the logitlog calculation to calculate. This issue can only be identified in the Atellica graphical view of the calibration. In most of the cases when this has occurred, it is picked up by the QC generating a Math Error, however, there are reports of QC shifts after calibration without the Math Error flagged that may be related to this issue. Results reported with STFR Level 1, with a concentration less than 1.7mg/L, using TF10159 and TF10161 can be underestimated by up to 30%. This issue has been reported with reagent lots 575475 and 562691, calibrator lots 537725 and 562696. No other complaints received.
Distribution Pattern
US Nationwide distribution in the state of IL.
Lot / Code Information
UDI-DI (GTIN): 05055273215564 All lots within expiry
Other Recalls from Randox Laboratories Ltd.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2425-2024 | Class II | RX Series CYSC- Cystatin C Reagent -Intended fo... | Jun 7, 2024 |
| Z-1786-2024 | Class III | Evidence MultiSTAT with software v 3.7-Analyzer... | Apr 5, 2024 |
| Z-1759-2024 | Class II | Clinical Chemistry Calibration Serum (Catalog n... | Mar 5, 2024 |
| Z-1328-2024 | Class II | Liquid Protein Calibrators. C3 and Haptoglobin ... | Mar 1, 2024 |
| Z-1369-2024 | Class II | Cystatin C Calibrator - In vitro diagnostic (IV... | Feb 14, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.